2015
DOI: 10.7439/ijbar.v6i1.1419
|View full text |Cite
|
Sign up to set email alerts
|

HER-2/neu expression in cervical intraepithelial neoplasia and cervical carcinoma

Abstract: Objectives: 1) To study the expression of HER-2 in Cervical Intraepithelial Neoplasia (CIN) and Cervical carcinoma 2) To correlate expression of HER-2 with histological type, grade and stage of tumor. Methods: A total of 34 cases were collected during the period from October 2012 to June 2014. Clinical data was collected from medical records. The histopathology slides were analyzed and immunohistochemical (IHC) studies were done on suitable blocks with marker HER-2. Results: Thirty four specimens including 20 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
4
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 14 publications
2
4
0
Order By: Relevance
“…This discrepancy may be due the use of different immunohistochemical clones, the number of examined cases or the selection criteria that implied further study on a larger scale. Tessa and Raghuveer [21] assessed the expression HER-2 in cervical cancer and proved that it was positively associated with increasing the grade of cancer, presence of lymph node metastases and parametrial spread which was in agree with our results. Our results were also compatible with Park et al [22] who studied Her2 amplification in colon cancer and reported that it was associated with higher rates of nodal metastasis and decreased patient survival.…”
Section: Discussionsupporting
confidence: 82%
“…This discrepancy may be due the use of different immunohistochemical clones, the number of examined cases or the selection criteria that implied further study on a larger scale. Tessa and Raghuveer [21] assessed the expression HER-2 in cervical cancer and proved that it was positively associated with increasing the grade of cancer, presence of lymph node metastases and parametrial spread which was in agree with our results. Our results were also compatible with Park et al [22] who studied Her2 amplification in colon cancer and reported that it was associated with higher rates of nodal metastasis and decreased patient survival.…”
Section: Discussionsupporting
confidence: 82%
“…In the study done by Joseph et al, 2015, all cases of squamous cell carcinoma showed HER 2 expression, with 1+ positivity in 10% of cases, 2+ positivity in 35% of cases and 3+ positivity in 55% of cases. 5 In a study by Hale et al (1992), it was reported that HER 2 expression was found in 38% cases of squamous cell carcinoma, findings are quite similar to our study. 9 Gupta et al (2009), reported that 53.17% of cases of Squamous cell carcinoma showed HER 2 positivity.…”
Section: Role Of Her 2 Immunostaining In Various Aspects Of Cervical ...supporting
confidence: 91%
“…In a study published by Protrka et al, 2007, expression of HER 2 in LSIL was found in 56.3% of cases and in HSIL it was reported in 81.8% of cases. 4 In a study by Joseph et al (2015), 70% of cases with CIN showed HER 2 positivity 5 . In a study conducted by Gupta et al (2009), 60% of CIN cases showed positivity of HER 2, most of them were of 1+ and 2+ positivity, none of them expressed 3+ positivity.…”
Section: Role Of Her 2 Immunostaining In Various Aspects Of Cervical ...mentioning
confidence: 97%
See 2 more Smart Citations